Tower Research Capital LLC (Trc) Sage Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 734 shares of SAGE stock, worth $7,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares

734

Previous 3,668 79.99%

Holding current value

$7,795

Previous $79,000 83.54%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$18.62 - $26.95 $54,631 - $79,071	-2,934 Reduced 79.99%	734 $13,000
Q4 2023 Feb 13, 2024	SELL	$17.1 - $22.26 $23,632 - $30,763	-1,382 Reduced 27.37%	3,668 $79,000
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $35,979 - $105,209	2,148 Added 74.02%	5,050 $103,000
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $8,170 - $11,967	-201 Reduced 6.48%	2,902 $136,000
Q1 2023 May 09, 2023	BUY	$37.27 - $46.57 $83,261 - $104,037	2,234 Added 257.08%	3,103 $130,000

Q4 2022 Feb 10, 2023	SELL	$32.2 - $43.61 $326,830 - $442,641	-10,150 Reduced 92.11%	869 $33,000
Q3 2022 Nov 10, 2022	SELL	$32.28 - $43.27 $339,359 - $454,897	-10,513 Reduced 48.83%	11,019 $432,000
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $75,349 - $104,016	2,738 Added 14.57%	21,532 $695,000
Q1 2022 May 12, 2022	BUY	$30.71 - $45.71 $277,188 - $412,578	9,026 Added 92.4%	18,794 $622,000
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $141,013 - $179,253	3,805 Added 63.81%	9,768 $415,000
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $203,997 - $290,693	5,067 Added 565.51%	5,963 $264,000
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $5,268 - $7,611	-96 Reduced 9.68%	896 $51,000
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $457,600 - $626,714	-6,477 Reduced 86.72%	992 $74,000
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $326,920 - $498,468	5,597 Added 298.99%	7,469 $646,000
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $89,622 - $136,078	-2,179 Reduced 53.79%	1,872 $114,000
Q2 2020 Aug 13, 2020	BUY	$25.95 - $43.15 $105,123 - $174,800	4,051 New	4,051 $168,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $57,033 - $168,460	-2,181 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$60.18 - $154.77 $102,967 - $264,811	1,711 Added 364.04%	2,181 $157,000
Q3 2019 Nov 05, 2019	SELL	$140.29 - $189.96 $19,360 - $26,214	-138 Reduced 22.7%	470 $66,000
Q2 2019 Aug 13, 2019	BUY	$157.85 - $183.09 $95,972 - $111,318	608 New	608 $111,000
Q4 2018 Feb 14, 2019	SELL	$81.94 - $139.71 $9,505 - $16,206	-116 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $64,359 - $78,772	-466 Reduced 80.07%	116 $16,000
Q2 2018 Aug 15, 2018	BUY	$140.36 - $175.76 $81,689 - $102,292	582 New	582 $91,000
Q4 2017 Feb 09, 2018	SELL	$60.72 - $167.34 $335,478 - $924,553	-5,525 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $339,235 - $489,073	5,525	5,525 $344,000

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $631M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Sage Therapeutics, Inc. Transaction History